Ephs and Ephrins in malignant gliomas

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Growth Factors

• Publication date

  2014-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3109/08977194.2014.985787PMID 25418012PMCID PMC4693299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eph receptor tyrosine kinases in cancer stem cells.

  2015cited by this paper
• Sorafenib/Regorafenib and Lapatinib Interact to kill CNS Tumor Cells

  2015cited by this paper
• Abrogation of radioresistance in glioblastoma stem‐like cells by inhibition of ATM kinase

  2015cited by this paper
• Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.

  2014cited by this paper
• Effect of EPH-ephrin signaling on the growth of human leukemia cells.

  2014cited by this paper
• Eph receptors as therapeutic targets in glioblastoma

  2014cited by this paper
• The role of the Eph/ephrin-system in atherosclerotic plaque development: a complex puzzle.

  2014cited by this paper
• Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation

  2014cited by this paper
• Axon guidance in the auditory system: multiple functions of Eph receptors.

  2014cited by this paper
• Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation

  2014cited by this paper
• EphA7 signaling guides cortical dendritic development and spine maturation

  2014cited by this paper
• Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.

  2014cited by this paper
• Glioblastoma‐associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties

  2014cited by this paper
• Immunotherapy advances for glioblastoma.

  2014cited by this paper
• [Anti-angiogenic therapy for malignant glioma].

  2014cited by this paper
• EPH-Ephrin signaling

  2014cited by this paper
• Molecular biology of gliomas: present and future challenges

  2014cited by this paper
• Spatial organization of EphA2 at the cell-cell interface modulates trans-endocytosis of ephrinA1.

  2014cited by this paper
• Antiangiogenic Therapy Inhibits the Recruitment of Vascular Accessory Cells to the Perivascular Niche in Glioma Angiogenesis

  2014cited by this paper
• CNS macrophages and peripheral myeloid cells in brain tumours

  2014cited by this paper
• Ephrin (Eph) receptor A1, A4, A5 and A7 expression in human non-small cell lung carcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival

  2014cited by this paper
• Glioblastoma multiforme: State of the art and future therapeutics

  2014cited by this paper
• Adoptive immunotherapy for cancer

  2014cited by this paper
• The role of Src family kinases in growth and migration of glioma stem cells

  2014cited by this paper
• Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.

  2014cited by this paper
• Glioblastoma – A tale of two tumors: Case comparison and literature review

  2014cited by this paper
• Targeting tumor suppressor p53 for cancer therapy: strategies, challenges and opportunities.

  2014cited by this paper
• The role of ephrins' receptors and ephrins' ligands in normal placental development and disease

  2014cited by this paper
• EphA2 Promotes Infiltrative Invasion of Glioma Stem Cells in vivo through Crosstalk with Akt and Regulates Stem Properties

  2014cited by this paper
• Stem cells and gliomas: past, present, and future

  2014cited by this paper
• A randomized trial of bevacizumab for newly diagnosed glioblastoma.

  2014cited by this paper
• ADAM12-cleaved ephrin-A1 contributes to lung metastasis

  2014cited by this paper
• Ephrin signalling in the developing nervous system.

  2014cited by this paper
• Therapeutic targeting of EPH receptors and their ligands

  2013cited by this paper
• Phase I Trial, Pharmacokinetics, and Pharmacodynamics of Vandetanib and Dasatinib in Children with Newly Diagnosed Diffuse Intrinsic Pontine Glioma

  2013cited by this paper
• Emerging Biomarkers in Glioblastoma

  2013cited by this paper
• PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1

  2013cited by this paper
• Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase*

  2013influential reference
• T cells redirected to EphA2 for the immunotherapy of glioblastoma.

  2013cited by this paper
• Convection-Enhanced Delivery for Targeted Delivery of Antiglioma Agents: The Translational Experience

  2013cited by this paper
• Pancreatic cancer.

  2013cited by this paper
• EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

  2013influential reference
• Pronounced hypoxia in the subventricular zone following traumatic brain injury and the neural stem/progenitor cell response

  2013cited by this paper
• Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer.

  2013cited by this paper
• Receptor tyrosine kinases: principles and functions in glioma invasion.

  2013cited by this paper
• Enhanced expression of EphrinB1 is associated with lymph node metastasis and poor prognosis in breast cancer

  2013cited by this paper
• Adoptive Cell Therapies for Glioblastoma

  2013cited by this paper
• Regulating DNA replication in bacteria.

  2013cited by this paper
• Eph/Ephrin signalling maintains eye field segregation from adjacent neural plate territories during forebrain morphogenesis

  2013cited by this paper
• Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.

  2013influential reference
• Targeting Tregs in Malignant Brain Cancer: Overcoming IDO

  2013cited by this paper
• Ephrin-A1/EphA4-mediated adhesion of monocytes to endothelial cells.

  2013influential reference
• High-level expression of a full-length Eph receptor.

  2013influential reference
• Eph receptor signaling and ephrins.

  2013cited by this paper
• Expression of EphrinB2 and EphB4 in glioma tissues correlated to the progression of glioma and the prognosis of glioblastoma patients

  2012cited by this paper
• EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase

  2012cited by this paper
• EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.

  2012influential reference
• Eph/Ephrin signaling in injury and inflammation.

  2012cited by this paper
• Ephs and ephrins in cancer: ephrin-A1 signalling.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• Expression and Activation of EphA4 in the Human Brain After Traumatic Injury

  2012cited by this paper
• A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo

  2012cited by this paper
• Concepts and consequences of Eph receptor clustering.

  2012cited by this paper
• Recent developments on immunotherapy for brain cancer

  2012cited by this paper
• EphrinA1 Is Released in Three Forms from Cancer Cells by Matrix Metalloproteases

  2012cited by this paper
• Convection-enhanced delivery of therapeutic agents into the brain.

  2012cited by this paper
• The molecular profile of microglia under the influence of glioma.

  2012cited by this paper
• Non-SH2/PDZ reverse signaling by ephrins.

  2012cited by this paper
• The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.

  2012cited by this paper
• Pathway inhibition: emerging molecular targets for treating glioblastoma.

  2011cited by this paper
• Role of Eph/ephrin tyrosine kinase in malignant glioma.

  2011cited by this paper
• Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

  2011cited by this paper
• Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

  2011cited by this paper
• Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis.

  2011cited by this paper
• The brain tumor microenvironment

  2011influential reference
• Brain cancer immunoediting: novel examples provided by immunotherapy of malignant gliomas

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells.

  2011cited by this paper
• The brain tumor microenvironment

  2011cited by this paper
• Molecular mechanisms of tumor angiogenesis.

  2011cited by this paper
• Regorafenib (BAY 73‐4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

  2011cited by this paper
• A hierarchy of self-renewing tumor-initiating cell types in glioblastoma.

  2010cited by this paper
• Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis

  2010influential reference
• Macrophages, innate immunity and cancer: balance, tolerance, and diversity.

  2010cited by this paper
• Restriction of Receptor Movement Alters Cellular Response: Physical Force Sensing by EphA2

  2010influential reference
• Tumors as organs: complex tissues that interface with the entire organism.

  2010cited by this paper
• EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.

  2009influential reference
• Control of extracellular matrix assembly along tissue boundaries via Integrin and Eph/Ephrin signaling

  2009influential reference
• Convection-enhanced delivery for the treatment of brain tumors

  2009cited by this paper
• The phosphorylation of ephrin‐B2 ligand promotes glioma cell migration and invasion

  2009influential reference
• EphrinA5 acts as a tumor suppressor in glioma by negative regulation of epidermal growth factor receptor

  2009influential reference
• Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype.

  2009influential reference
• Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor

  2008influential reference
• Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer

  2008cited by this paper
• An Integrated Genomic Analysis of Human Glioblastoma Multiforme

  2008cited by this paper
• Eph/ephrin signaling: networks.

  2008cited by this paper
• Erythropoietin‐producing hepatocyte B6 variant‐derived peptides with the ability to induce glioma‐reactive cytotoxic T lymphocytes in human leukocyte antigen‐A2+ glioma patients

  2008influential reference
• Interleukin-13 Receptor α2, EphA2, and Fos-Related Antigen 1 as Molecular Denominators of High-Grade Astrocytomas and Specific Targets for Combinatorial Therapy

  2008influential reference
• Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.

  2008cited by this paper
• EphA4 promotes cell proliferation and migration through a novel EphA4-FGFR1 signaling pathway in the human glioma U251 cell line

  2008cited by this paper

• The Clinical Relevance of the EPH/Ephrin Signaling Pathway in Pediatric Solid and Hematologic Malignancies

  2024cites this paper
• EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter

  2023cites this paper
• Pharmacological characterization of second generation FXR agonists as effective EphA2 antagonists: a successful application of target hopping approach.

  2023cites this paper
• EphrinA5 regulates cell motility by modulating the targeting of DNMT1 to the Ncam1 promoter via lncRNA/DNA triplex formation

  2023cites this paper
• Immunotherapeutic treatments for spinal and peripheral nerve tumors: a primer.

  2022cites this paper
• Tracing the origins of glioblastoma by investigating the role of gliogenic and related neurogenic genes/signaling pathways in GBM development: a systematic review

  2022cites this paper
• Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids

  2022cites this paper
• Suppression mechanisms on proliferation of glioma U251 cells by FePt nanoparticles through intracellular oxidative stress

  2022cites this paper
• Identification of an endoplasmic reticulum stress-related signature associated with clinical prognosis and immune therapy in glioma

  2022cites this paper
• Tumor Microenvironment in Glioma Invasion

  2022cites this paper
• Netrin-1 in Glioblastoma Neovascularization: The New Partner in Crime?

  2021cites this paper
• The Expression of the Cancer-Associated lncRNA Snhg15 Is Modulated by EphrinA5-Induced Signaling

  2021influential citation
• Inhibition of DHFR targets the self-renewing potential of brain tumor initiating cells.

  2021cites this paper
• Eriodictyol inhibits glioblastoma migration and invasion by reversing EMT via downregulation of the P38 MAPK/GSK-3β/ZEB1 pathway.

  2021cites this paper
• The Presence and Potential Role of ALDH1A2 in the Glioblastoma Microenvironment

  2021cites this paper
• A review on the role of different ephrins in glioma.

  2021cites this paper
• The IL13α 2R paves the way for anti-glioma nanotherapy.

  2021cites this paper
• TAGAP instructs Th17 differentiation by bridging Dectin activation to EPHB2 signaling in innate antifungal response

  2020cites this paper
• Extracellular Vesicles Involvement in the Modulation of the Glioblastoma Environment

  2020cites this paper
• EFNB2 facilitates cell proliferation, migration, and invasion in pancreatic ductal adenocarcinoma via the p53/p21 pathway and EMT.

  2020cites this paper
• Prognostic Markers Identification in Glioma by Gene Expression Profile Analysis

  2020cites this paper
• Receptor Tyrosine Kinase Interaction with the Tumor Microenvironment in Malignant Progression of Human Glioblastoma

  2018cites this paper
• Erythropoietin Promotes Glioblastoma via miR-451 Suppression.

  2017cites this paper
• Mechanisms of miRNA expression in regulating glioma invasion

  2016cites this paper
• Simultaneous targeting of Eph receptors in glioblastoma

  2016cites this paper
• Mechanisms regulating glioma invasion.

  2015cites this paper
• Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond.

  2015cites this paper